Shingleton Bradford J, Laul Anupam, Nagao Karina, Wolff Brian, O'Donoghue Mark, Eagan Edward, Flattem Nancy, Desai-Bartoli Sonalee
Private Practice, Boston, Massachusetts, USA.
J Cataract Refract Surg. 2008 Nov;34(11):1834-41. doi: 10.1016/j.jcrs.2008.07.025.
To assess the effect of phacoemulsification with posterior chamber intraocular lens (IOL) implantation performed by a single surgeon on intraocular pressure (IOP) and glaucoma medication requirements in pseudoexfoliation (PFX) eyes with or without glaucoma.
Private practice, Boston, Massachusetts, USA.
This retrospective analysis comprised 1122 eyes with PFX having uneventful phacoemulsification with IOL implantation. Of the eyes, 882 did not have glaucoma (PFX group) and 240 had glaucoma (PXG group). A comparative outcomes analysis was performed; the analysis focused on IOP and change in glaucoma medication requirements between the 2 groups.
The mean IOP was statistically significantly reduced through 7 years postoperatively compared with preoperatively in the PFX group. The PXG group had reduced mean IOP for 1 year and reduced glaucoma medication requirements at almost all postoperative time intervals. Higher mean preoperative IOP was associated with a greater reduction in mean IOP postoperatively in both groups. Intraocular pressure spikes (> 30 mm Hg) 1 day postoperatively occurred in 4% in the PFX group and 17% in the PXG group. Postoperatively, 2.7% of PFX eyes progressed to a need for glaucoma medication and 3.7% of PXG eyes progressed to a need for laser and/or glaucoma surgery.
A long-term reduction in mean IOP occurred in PFX eyes with and without glaucoma. The IOP reduction was proportional to the preoperative IOP; higher preoperative IOP was associated with a greater reduction in IOP. Glaucoma progression in both groups was low, suggesting a protective effect of phacoemulsification on IOP in these eyes.
评估由同一位外科医生进行的白内障超声乳化吸除联合后房型人工晶状体(IOL)植入术对伴有或不伴有青光眼的假性剥脱(PFX)眼的眼压(IOP)及青光眼药物治疗需求的影响。
美国马萨诸塞州波士顿的私人诊所。
这项回顾性分析纳入了1122只接受了平稳的白内障超声乳化吸除联合IOL植入术的PFX眼。其中,882只眼无青光眼(PFX组),240只眼患有青光眼(PXG组)。进行了对比结果分析;该分析聚焦于两组之间的IOP及青光眼药物治疗需求的变化。
与术前相比,PFX组术后7年平均IOP有统计学意义的显著降低。PXG组术后1年平均IOP降低,且在几乎所有术后时间间隔内青光眼药物治疗需求均减少。两组术前平均IOP越高,术后平均IOP降低幅度越大。术后1天,PFX组4%的眼出现眼压峰值(>30 mmHg),PXG组为17%。术后,2.7%的PFX眼进展为需要青光眼药物治疗,3.7%的PXG眼进展为需要激光和/或青光眼手术。
伴有和不伴有青光眼的PFX眼平均IOP均出现长期降低。IOP降低与术前IOP成比例;术前IOP越高,IOP降低幅度越大。两组青光眼进展率均较低,提示白内障超声乳化吸除术对这些眼的IOP有保护作用。